Tocilizumab in rheumatoid arthritis: A case study of safety evaluations of a large postmarketing data set from multiple data sources-Reference-Cited by-同舟云学术

Tocilizumab in rheumatoid arthritis: A case study of safety evaluations of a large postmarketing data set from multiple data sources

Published:2015-02 Issue:4 Volume:44 Page:381-388
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Curtis Jeffrey R.,Perez-Gutthann Susana,Suissa Samy,Napalkov Pavel,Singh Natasha,Thompson Liz,Porter-Brown Benjamin

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference35 articles.

1. Utilization of biologic agents in rheumatoid arthritis in the United States: analysis of prescribing patterns in 16,752 newly diagnosed patients and patients new to biologic therapy;Yazici;Bull NYU Hosp Jt Dis,2008

2. Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease: attrition rate and evolution of disease;Vander Cruyssen;Arthritis Res Ther,2010

3. Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period;Gomez-Reino;Arthritis Res Ther,2006

4. Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study;Hyrich;Arthritis Rheum,2007

5. Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders;Buch;Rheumatology (Oxford),2007

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitigating target interference challenges in bridging immunogenicity assay to detect anti-tocilizumab antibodies;Bioanalysis;2024-06-17

2. The dual role of interleukin-6 in Crohn’s disease pathophysiology;Frontiers in Immunology;2023-12-01

3. Interleukin-6 in retinal diseases: From pathogenesis to therapy;Experimental Eye Research;2023-08

4. Tocilizumab in Behçet Disease: A Multicenter Study of 30 Patients;The Journal of Rheumatology;2023-03-01

5. Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis;Frontiers in Cardiovascular Medicine;2022-10-24